Press Release - Parker Waichman LLP Reports Plaintiffs Win Motion to Centralize All Pending National Elmiron® Retinal Damage Lawsuits to the District of New Jersey
PORT WASHINGTON, N.Y., Dec. 18, 2020 /PRNewswire/ -- Parker Waichman LLP, a national law firm actively involved in the Elmiron® litigation, announced today that plaintiffs were successful in their motion, under 28 USC § 1407, to centralize all pending Elmiron injury lawsuits filed in federal courts across the country in the District of New Jersey.
The United States Judicial Panel on Multidistrict Litigation, in the matter of In re Elmiron (pentosan polysulfate sodium) Products Liability Litigation, issued a Transfer Order (Case MDL No. 2973; Document 158) on December 15, 2020 initiating the transfer of all federally-filed Elmiron injury lawsuits to the District of New Jersey and assigning the Honorable Brian R. Martinotti to all coordinated or consolidated proceedings.
According to the Transfer Order, there was no responding party who opposed the centralization motion. The United States Judicial Panel on Multidistrict Litigation ruled that the District of New Jersey was the appropriate transferee district due to the convenience of the parties and witnesses involved in the litigation. The Panel also recognized that many of the defendants, witnesses, and documents are located in New Jersey, and centralizing the litigation would eliminate duplicative discovery, avoid inconsistent pretrial rulings; and conserve the resources of the parties, their counsel, and the judiciary. The JPML Panel stated that Judge Brian R. Martinotti is well-versed in the complexities of multidistrict litigation and that he has initiated the necessary steps of organizing the litigation, which is expected to grow by several hundreds of cases.
The lawsuits allege Elmiron causes permanent and severe retinal injuries, notably atypical or pigmentary maculopathy.
Attorney Jerrold S. Parker, the founding partner of Parker Waichman LLP, who has battled drug companies on behalf of injury victims, in courtrooms throughout the United States for several decades, said, "The extent of Elmiron® damage is some of the most significant I have ever seen. Sadly, we are now seeing many Elmiron® users who are facing serious, irreversible vision issues and even blindness as a result of the use of this drug and may have very limited, if any, efficacy."
Parker Waichman LLP's website provides a copy of the Transfer Order.
Parker Waichman LLP, a national law firm, has been actively involved in Elmiron® litigation.
Do You Have a Case? If you or a loved one were prescribed Elmiron and suffered vision problems or eye damage, call our firm at 1-800-YOURLAWYER (1-800-968-7529) for your free case review by our Elmiron Lawsuit Lawyers.
Parker Waichman LLP has recovered billions of dollars for people harmed, injured, or killed by dangerous medications and other acts of negligence. There is no obligation, and there are no expenses or legal fees unless you win your Elmiron® Lawsuit. To receive your free case review, call Parker Waichman LLP at 1-800-YOURLAWYER (1-800-968-7529) or visit the firm's website at www.yourlawyer.com.
SOURCE Parker Waichman LLP
Share this article